₹2566.65 10.9 0.4%
Last Trade - 13/04/21
| Market Cap | £4.20bn |
| Enterprise Value | £4.64bn |
| Revenue | £774.6m |
| Position in Universe | 87th / 3106 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 46,535 | 66,869 | 58,569 | 59,498 | 76,728 | 79,393 | 80,066 | 90,304 | +11.3% | ||
| +13.3 | +147.9 | -49.6 | -28.3 | +5.6 | +36.0 | +24.3 | +16.8 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products. The Company operates in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, anti-diabetics and pain management segments. The Company offers products in various categories, including tablets, capsule and parenteral. Its geographical segments include India and outside India. It manufactures various active pharmaceutical ingredients (APIs), such as Nicorandil, Risperidone, Venlafaxine Hydrochloride, Ropinarole Hydrochloride, Duloxetine Hydrochloride, Ormeloxifen Hydrochloride, Nebivolol Hydrochloride, Lamotrigine and Sertraline Hydrochloride. The Company's subsidiaries include Heumann Pharma GmbH & Co., Torrent Pharma GmbH, Heunet Pharma GmbH, Norispharm GmbH, Torrent Pharma (Thailand) Co. Ltd., Torrent Pharma S.R.L., Aptil Pharma Limited and Laboratories Torrent Malaysia Sdn. Bhd.
| Last Annual | March 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | July 15, 1972 |
| Public Since | November 3, 1994 |
| No. of Shareholders: | 37,475 |
| No. of Employees: | 12,881 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | S&P BSE 100 , |
| Exchange | National Stock Exchange of India |
| Shares in Issue | 169,222,720 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Torrent House Off Ashram Road, AHMEDABAD, 380009, India |
| Web | http://www.torrentpharma.com/ |
| Phone | +91 79 26599000 |
| Contact | () |
| Auditors | BSR & Co. LLP |
As of 13/04/21, shares in Torrent Pharmaceuticals are trading at ₹2566.65, giving the company a market capitalisation of £4.20bn. This share price information is delayed by 15 minutes.
Shares in Torrent Pharmaceuticals are currently trading at ₹2566.65 and the price has moved by 8.06% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Torrent Pharmaceuticals price has moved by -33.29% over the past year.
Of the analysts with advisory recommendations for Torrent Pharmaceuticals, there are there are currently 6 "buy" , 9 "hold" and 2 "sell" recommendations. The overall consensus recommendation for Torrent Pharmaceuticals is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Torrent Pharmaceuticals is scheduled to issue upcoming financial results on the following dates:
The Torrent Pharmaceuticals dividend yield is 1.44% based on the trailing twelve month period.
Last year, Torrent Pharmaceuticals paid a total dividend of 37, and it currently has a trailing dividend yield of 1.44%. Looking ahead, Torrent Pharmaceuticals has not announced an ex-dividend date yet.
Torrent Pharmaceuticals has yet to annouce their ex-dividend date. The historic dividend yield on Torrent Pharmaceuticals shares is currently 1.44%.
To buy shares in Torrent Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Torrent Pharmaceuticals are currently trading at ₹2566.65, giving the company a market capitalisation of £4.20bn.
Here are the trading details for Torrent Pharmaceuticals:
Based on an overall assessment of its quality, value and momentum, Torrent Pharmaceuticals is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Torrent Pharmaceuticals are currently priced at ₹2566.65. At that level they are trading at 9.16% discount to the analyst consensus target price of 0.00.
Analysts covering Torrent Pharmaceuticals currently have a consensus Earnings Per Share (EPS) forecast of 71.545 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Torrent Pharmaceuticals. Over the past six months, the relative strength of its shares against the market has been -24.12%. At the current price of ₹2566.65, shares in Torrent Pharmaceuticals are trading at -2.62% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Torrent Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is 36.54. The shares are currently trading at ₹2566.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Torrent Pharmaceuticals's management team is headed by:
Here are the top five shareholders of Torrent Pharmaceuticals based on the size of their shareholding:
